The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?

Acta Dermato-Venereologica

Volumn 85, Issue 3, 2005, Pages 203-205

  Faergemann, Jan ^a   Hedner, Thomas ^a   Larsson, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotics; Antimicrobial agents; Diols; Multi resistance

Indexed keywords

ANTIBIOTIC AGENT; BIOCIDE; PENTANE 1,5 DIOL; TOPICAL ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER; AEROBIC BACTERIUM; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; GLYCOLS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; SKIN DISEASES, BACTERIAL;

EID: 18844378348     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410026128     Document Type: Article

References (29)

1. Borg MA. Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings. J Hosp Infect 2003; 54: 316-318.
2. Udo EE, Jacob LE, Mathew B. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance. J Med Microbiol 2001; 50: 909-915.
3. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003; 37: 326-332.
4. Kuriyama T, Williams DW, Patel M, Lewis MA, Jenkins LE, Hill DW, et al. Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales. J Med Microbiol 2003; 52: 821-827.
5. Makanera A, Ariel G, Gautier V, Manai M. Molecular epidemiology and characterization of plasmid-encoded beta-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins. J Clin Microbiol 2003; 41: 2940-2945.
6. Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32: 1085-1089.
7. Tenover FC. Novel and emerging mechanisms of antimicrobial resistance in nosocomial pathogens. Am J Med 1991;91(3B):76S-81S.
8. McDermott PF, Walker RD, White DG. Antimicrobials: modes of action and mechanisms of resistance. Int J Toxicol 2003; 22: 135-143.
9. Raz R. The clinical impact of multiresistant gram-positive microorganisms in long-term care facilities. J Am Med Dir Assoc 2003; 4(Suppl 1):S100-S104.
10. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003; 58: 525-527.
11. Tveten Y, Jenkins A, Kristiansen B-E. A fusidic acid resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50: 873-876.
12. Österlund A, Edén T, Olsson-Liljequist S, Haeggman S, Kahlmeter G. The clonal spread among Swedish children of a Staphylococcus aureus resistant to fusidic acid. Scand J Infect Dis 2002; 34: 729-734.
13. Brown EM, Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 2002; 359: 803.
14. Arkwright PD, Daniel TO, Sanyal D, David TJ, Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-speciality center. Arch Dermatol 2002; 138: 939-941.
15. Gilbert P, McBail AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16: 189-208.
16. Levy SB. Antimicrobial consumer products. Arch Dermatol 2002; 138: 1087-1088.
17. Tan L, Nielsen NH, Young DC, Trizna Z. Use of antimicrobial agents in consumer products. Arch Dermatol 2002; 138: 1082-1086.
18. Suller MT, Russel AD. Antibiotic and biocide resistance in methicillin-resistant Staphyloccoccus aureus and vancomycin-resistant Enterococcus. J Hosp Infect 1999; 43: 281-291.
19. Perencevich EN, Wong MT, Harris AD. National and regional assessment of the antibacterial soap market: a step forward determining the impact of prevalent antibacterial soaps. Am J Infect Control 2001; 29: 281-283.
20. Herrera D, Roldan S, Santacruz I, Santos S, Masdevall M, Sanz M. Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouth-rinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol 2003; 30: 307-314.
21. Tattawasart U, Maillard JY, Furr JR, Russell AD. Development of resistance to chlorhexidine diacetate and cetylpyridinum chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999; 42: 219-229.
22. Rowe VK, Wolf MA. Glycols; Table 50.1 Physical and chemical properties of common glycols (diols). In: Clayton GD, Clayton FE, eds. Patty's industrial hygiene and toxicology, 3rd edn., New York: John Wiley & Sons, 1982: 3818-3819.
23. Smyth HF, Carpenter CP, Weil CS, Pozzani UC, Striegel JA. Range finding toxicity data: List VI. Am Ind Hyg Assoc J 1962; 23: 95-97.
24. Faergemann J, Fredriksson T. The antimycotic activity in vitro of five diols. Sabouraudia 1980; 18: 287-293.
25. Faergemann J. Pityrosporum yeasts - what's new? Mycoses 1997; 40(Suppl 1):29-32.
26. Frankenfeld JW, Miller SA. High energy food supplements comprising linear aliphatic 1,3 diols. USA patent 3791241, 1974, Feb 12, pp. 0-10.
27. Randall LP, Ridley AM, Cooles SW, Sharma M, Sayers AR, Pumbwe L, et al. Prevalence of multiple antibiotic resistance in 433 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother 2003; 13: 423-427.
28. Frankenfeld JW. Preservation of grain with aliphatic 1,3-diols and their esters. J Agric Food Chem 1975; 23: 418-425.
29. Gessner PK. Studies in detoxification; 80. The metabolism of glycols. Biochemistry 1960; 74: 1-5.